{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:42:29Z","timestamp":1792802549409,"version":"4.5.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000092","name":"National Library of Medicine","doi-asserted-by":"crossref","award":["R01LM011986"],"award-info":[{"award-number":["R01LM011986"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM122845"],"award-info":[{"award-number":["R01GM122845"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1006619","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T13:24:00Z","timestamp":1560777840000},"page":"e1006619","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Rational discovery of dual-indication multi-target PDE\/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology"],"prefix":"10.1371","volume":"15","author":[{"given":"Hansaim","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-9123","authenticated-orcid":true,"given":"Di","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Krawczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-2111","authenticated-orcid":true,"given":"Lei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-017-0262-x","article-title":"Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT Study","volume":"9","author":"JM Gabin","year":"2017","journal-title":"Alzheimer\u2019s research & therapy"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"FL Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2018.00324","article-title":"Corroboration of a major role for herpes simplex virus type 1 in Alzheimer\u2019s disease","volume":"10","author":"RF Itzhaki","year":"2018","journal-title":"Frontiers in aging neuroscience"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/bjc.2017.88","article-title":"Tyrosine kinase-targeting drugs-associated heart failure","volume":"116","author":"N Gronich","year":"2017","journal-title":"Br J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40425-016-0152-y","article-title":"Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy","volume":"4","author":"L Heinzerling","year":"2016","journal-title":"J Immunother Cancer"},{"issue":"19","key":"ref6","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"A Anighoro","year":"2014","journal-title":"J Med Chem"},{"issue":"21","key":"ref7","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"R Morphy","year":"2005","journal-title":"J Med Chem"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"A Cavalli","year":"2008","journal-title":"J Med Chem"},{"issue":"24","key":"ref9","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1021\/jm020120c","article-title":"Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer\u2019s disease","volume":"45","author":"J Sterling","year":"2002","journal-title":"Journal of medicinal chemistry"},{"issue":"16","key":"ref10","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1021\/jm0603015","article-title":"The physicochemical challenges of designing multiple ligands","volume":"49","author":"R Morphy","year":"2006","journal-title":"J Med Chem"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jcim.6b00122","article-title":"Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound\u2013Kinase Activities: A Way toward Selective Promiscuity by Design?","volume":"56","author":"S Christmann-Franck","year":"2016","journal-title":"Journal of chemical information and modeling"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010611-134630","article-title":"Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs","volume":"52","author":"L Xie","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic Immunity Is Required for Effective Cancer Immunotherapy","volume":"168","author":"MH Spitzer","year":"2017","journal-title":"Cell"},{"issue":"8","key":"ref14","first-page":"786","article-title":"Treating cancer\u2019s kinase\u2019addiction'","volume":"10","author":"J Baselga","year":"2004","journal-title":"Nature medicine"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-13-1610","article-title":"Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies","volume":"20","author":"CM Lovly","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"P Sharma","year":"2017","journal-title":"Cell"},{"issue":"23","key":"ref17","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"R Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"206","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006548","article-title":"Systems pharmacology of adverse event mitigation by drug combinations","volume":"5","author":"S Zhao","year":"2013","journal-title":"Sci Transl Med"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nchembio.117","article-title":"Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases","volume":"4","author":"B Apsel","year":"2008","journal-title":"Nat Chem Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcvm.2018.00009","article-title":"Cardiotoxicity of Anticancer Therapeutics","volume":"5","author":"J Dong","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pcbi.0030217","article-title":"In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators","volume":"3","author":"L Xie","year":"2007","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"e1000423","DOI":"10.1371\/journal.pcbi.1000423","article-title":"Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis","volume":"5","author":"SL Kinnings","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"e1000387","DOI":"10.1371\/journal.pcbi.1000387","article-title":"Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors","volume":"5","author":"L Xie","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"e1000938","DOI":"10.1371\/journal.pcbi.1000938","article-title":"Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model","volume":"6","author":"RL Chang","year":"2010","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"e1000648","DOI":"10.1371\/journal.pcbi.1000648","article-title":"A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology","volume":"6","author":"JD Durrant","year":"2010","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"e1002037","DOI":"10.1371\/journal.pcbi.1002037","article-title":"Drug Discovery Using Chemical Systems Biology: Weak inhibition of multiple kinases may contribute to the anti-cancer effect of Nelfinavir","volume":"7","author":"L Xie","year":"2011","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijantimicag.2012.05.009","article-title":"Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence","volume":"40","author":"SJ Ho Sui","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.fjc.0000175454.69116.9","article-title":"Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone","volume":"46","author":"S Szilagyi","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 4","key":"ref29","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2105-8-S4-S9","article-title":"A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites","volume":"8","author":"L Xie","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"14","key":"ref30","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1073\/pnas.0704422105","article-title":"Detecting evolutionary relationships across existing fold space, using sequence order-independent profile-profile alignments","volume":"105","author":"L Xie","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"i305","DOI":"10.1093\/bioinformatics\/btp220","article-title":"A unified statistical model to support local sequence order independent similarity searching for ligand-binding sites and its application to genome-based drug discovery","volume":"25","author":"L Xie","year":"2009","journal-title":"Bioinformatics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"e1005135","DOI":"10.1371\/journal.pcbi.1005135","article-title":"Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing","volume":"12","author":"H Lim","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"ref34","article-title":"ANTENNA, a Multi-Rank, Multi-Layered Recommender System for Inferring Reliable Drug-Gene-Disease Associations: Repurpsing Diazoxide as an effective targeted anti-cancer therapy","author":"A Wang","year":"2018","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1535-7163.MCT-16-0876","article-title":"FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions","volume":"16","author":"M Larrosa-Garcia","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"ref36","article-title":"Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity","author":"AC Macleod","year":"2014","journal-title":"Molecular cancer therapeutics"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"e1004586","DOI":"10.1371\/journal.pcbi.1004586","article-title":"AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility","volume":"11","author":"PA Ravindranath","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"JN Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg1011s57","article-title":"The Catalogue of Somatic Mutations in Cancer (COSMIC)","author":"SA Forbes","year":"2008","journal-title":"Curr Protoc Hum Genet"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"MJ Keiser","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: tool for the unification of biology","volume":"25","author":"TGO Consortium","year":"2000","journal-title":"Nature Genet"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1091\/mbc.e11-07-0639","article-title":"The kinase activity of human Rio1 is required for final steps of cytoplasmic maturation of 40S subunits","volume":"23","author":"B Widmann","year":"2012","journal-title":"Molecular biology of the cell"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/rna.18810","article-title":"Human RioK3 is a novel component of cytoplasmic pre-40S pre-ribosomal particles","volume":"9","author":"K Baumas","year":"2012","journal-title":"RNA biology"},{"key":"ref44","article-title":"Kernel feature selection via conditional covariance minimization","author":"J Chen","year":"2017","journal-title":"Advances in Neural Information Processing Systems"},{"issue":"7391","key":"ref45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"issue":"Database issue","key":"ref46","first-page":"D955","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"J Pelletier","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ebiom.2017.04.015","article-title":"The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior","volume":"20","author":"F Weinberg","year":"2017","journal-title":"EBioMedicine"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1517\/14656566.2013.780031","article-title":"Protein kinase inhibitors against malignant lymphoma","volume":"14","author":"OJ D\u2019Cruz","year":"2013","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.65","article-title":"Bruton\u2019s tyrosine kinase inhibitors in B-cell non-Hodgkin\u2019s lymphomas","volume":"97","author":"L Alinari","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"ref51","article-title":"Compounds and compositions for the treatment of cancer","author":"TA Lewis","year":"2018","journal-title":"Google Patents"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nchembio.1337","article-title":"Metrics other than potency reveal systematic variation in responses to cancer drugs","volume":"9","author":"M Fallahi-Sichani","year":"2013","journal-title":"Nature chemical biology"},{"issue":"Database issue","key":"ref53","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"A Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"ref54","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"DS Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"ref55","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jcim.6b00122","article-title":"Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?","volume":"56","author":"S Christmann-Franck","year":"2016","journal-title":"J Chem Inf Model"},{"issue":"8","key":"ref56","doi-asserted-by":"crossref","first-page":"e0181585","DOI":"10.1371\/journal.pone.0181585","article-title":"Progress towards a public chemogenomic set for protein kinases and a call for contributions","volume":"12","author":"DH Drewry","year":"2017","journal-title":"PLoS One"},{"issue":"6367","key":"ref57","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4368","article-title":"The target landscape of clinical kinase drugs","volume":"358","author":"S Klaeger","year":"2017","journal-title":"Science"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/acs.jmedchem.6b01611","article-title":"Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay","volume":"60","author":"B Merget","year":"2017","journal-title":"J Med Chem"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"W Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12859-016-1433-7","article-title":"KinMap: a web-based tool for interactive navigation through human kinome data","volume":"18","author":"S Eid","year":"2017","journal-title":"BMC Bioinformatics"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T17:23:40Z","timestamp":1721409820000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006619"}},"subtitle":[],"editor":[{"given":"Rebecca C.","family":"Wade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1006619","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/465054","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]}}}